Vir Biotechnology, Inc.
VIR
$9.26
-$0.22-2.32%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 25,183.33% | -80.23% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 26,595.83% | -80.23% | |||
| Cost of Revenue | -41.60% | 55.30% | |||
| Gross Profit | 83.87% | -57.01% | |||
| SG&A Expenses | 6.23% | -0.23% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -35.47% | 44.97% | |||
| Operating Income | 72.32% | -46.26% | |||
| Income Before Tax | 73.58% | -47.10% | |||
| Income Tax Expenses | -181.55% | -1.18% | |||
| Earnings from Continuing Operations | 73.69% | -47.03% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 73.69% | -47.03% | |||
| EBIT | 72.32% | -46.26% | |||
| EBITDA | 73.54% | -47.35% | |||
| EPS Basic | 73.75% | -46.53% | |||
| Normalized Basic EPS | 75.38% | -52.22% | |||
| EPS Diluted | 73.75% | -46.53% | |||
| Normalized Diluted EPS | 75.38% | -52.22% | |||
| Average Basic Shares Outstanding | 0.21% | 0.35% | |||
| Average Diluted Shares Outstanding | 0.21% | 0.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||